Key Metrics
CiteScore 

10.4
Impact Factor 

5 - 10
SNIP 

1.43
Recommended pre-submission checks
Powered by 

Topics Covered on Clinical Immunology
Clinical Immunology Journal Specifications
| Overview | |
| Publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Clinical Immunology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Clinical Immunology
Vamifeport, a clinical stage oral ferroportin inhibitor, alleviates murine lupus nephritis: A pilot study.
- 1 Jun 2026
- Clinical immunology (Orlando, Fla.)
Efficacy and safety of telitacicept for myasthenia gravis in real-world practice and exploratory outcomes in the elderly subgroup.
- 1 Jun 2026
- Clinical immunology (Orlando, Fla.)
PLK2 facilitates Mycobacterium tuberculosis clearance via p38 MAPK-mediated ROS production.
- 1 Jun 2026
- Clinical immunology (Orlando, Fla.)
NF-κB1 haploinsufficiency due to a novel c.104delT variant in two patients with common variable immunodeficiency.
- 1 Jun 2026
- Clinical immunology (Orlando, Fla.)
Reconsidering the nosology of CYBB S333Y-associated adult-onset mycobacterial susceptibility.
- 1 Jun 2026
- Clinical immunology (Orlando, Fla.)
Relationship between repertoire diversity of B cell receptor immunoglobulin G heavy chain and infectious complications caused by encapsulated bacteria after allogeneic hematopoietic cell transplantation.
- 1 Jun 2026
- Clinical immunology (Orlando, Fla.)
Vamifeport, a clinical stage oral ferroportin inhibitor, alleviates murine lupus nephritis: A pilot study.
- 1 Jun 2026
- Clinical immunology (Orlando, Fla.)
Efficacy and safety of telitacicept for myasthenia gravis in real-world practice and exploratory outcomes in the elderly subgroup.
- 1 Jun 2026
- Clinical immunology (Orlando, Fla.)
PLK2 facilitates Mycobacterium tuberculosis clearance via p38 MAPK-mediated ROS production.
- 1 Jun 2026
- Clinical immunology (Orlando, Fla.)
NF-κB1 haploinsufficiency due to a novel c.104delT variant in two patients with common variable immunodeficiency.
- 1 Jun 2026
- Clinical immunology (Orlando, Fla.)
Reconsidering the nosology of CYBB S333Y-associated adult-onset mycobacterial susceptibility.
- 1 Jun 2026
- Clinical immunology (Orlando, Fla.)
Relationship between repertoire diversity of B cell receptor immunoglobulin G heavy chain and infectious complications caused by encapsulated bacteria after allogeneic hematopoietic cell transplantation.
- 1 Jun 2026
- Clinical immunology (Orlando, Fla.)